The 2024 Nobel Prize in Physiology or Medicine

2024 Nobel Prize in Physiology or Medicine:

The 2024 Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNAs (miRNAs), a novel mechanism of gene regulation. Their work, initially based on research using the roundworm Caenorhabditis elegans, revealed how miRNAs play a crucial role in regulating gene expression, influencing development and cellular function across many species, including humans.

The discovery of microRNAs (miRNAs):

Ambros and Ruvkun’s discovery has had significant implications for understanding how genes are regulated, with potential applications in cancer and cardiovascular disease treatments. Their work is a cornerstone of genetic research, and they previously shared the prestigious Lasker Award in 2008. The prize this year underscores the importance of basic scientific research in unlocking insights that could lead to future medical breakthroughs.

The discovery of microRNAs (miRNAs) is a significant advancement in molecular biology and gene regulation. It began in the early 1990s, when Victor Ambros and Gary Ruvkun independently identified small non-coding RNA molecules that regulate gene expression in the roundworm Caenorhabditis elegans. Their research focused on specific genetic mutations, including the lin-4 and lin-14 genes, that were linked to developmental timing in the worm.

Ambros first identified lin-4, which did not encode a protein but instead produced a small RNA molecule that was found to interact with the lin-14 gene, preventing its translation into protein. Ruvkun later discovered that this mechanism was widespread, identifying another miRNA, let-7, which functions similarly in many species, including humans. This finding showed that miRNAs were conserved across evolution and played a crucial role in regulating the expression of thousands of genes.

MiRNAs work by binding to complementary sequences on messenger RNA (mRNA), inhibiting their translation or leading to their degradation, thus finely tuning the levels of proteins produced by cells. Today, miRNAs are recognized as key regulators of various biological processes, including development, cell differentiation, and the immune response, with potential implications for treating diseases like cancer and heart disease.

About Victor Ambros & Gary Ruvkun:

Victor Ambros: Victor Ambros is an American developmental biologist known for his groundbreaking discovery of microRNAs (miRNAs). He was born in 1953 and grew up in Vermont, USA. Ambros completed his undergraduate studies at MIT and earned his Ph.D. in biology under the mentorship of Nobel laureate David Baltimore. After postdoctoral work with Robert Horvitz at MIT, Ambros began researching Caenorhabditis elegans, a model organism, leading to the discovery of the lin-4 gene in 1993. This was the first known miRNA, a non-coding RNA molecule that regulates gene expression by binding to complementary mRNA sequences.

Ambros' work on miRNAs, which are involved in numerous cellular processes such as development, differentiation, and disease, opened up a new field of genetic research. He has held faculty positions at Harvard, Dartmouth College, and the University of Massachusetts Medical School. Ambros’ research has earned him several prestigious awards, including the 2008 Lasker Award and the 2024 Nobel Prize in Medicine. He continues to work on miRNA-related research, contributing to the understanding of molecular genetics.

Gary Ruvkun: Gary Ruvkun, born in 1952, is a distinguished American geneticist, best known for his contributions to the discovery of miRNAs and their role in gene regulation. Ruvkun grew up in Berkeley, California, and pursued his undergraduate studies at the University of California, Berkeley, before completing his Ph.D. at Harvard University. He started working with Caenorhabditis elegans during his postdoctoral research with Robert Horvitz at MIT, where he met Victor Ambros.

Ruvkun’s major scientific breakthrough came when he discovered the let-7 miRNA in 2000, demonstrating that this regulatory RNA was conserved across species, from worms to humans. This finding showed that miRNAs are essential components of gene regulation across diverse organisms. Ruvkun has been a professor at Harvard Medical School since the late 1970s, focusing on molecular biology, genetics, and evolutionary biology.

Ruvkun has received numerous accolades, including the Lasker Award in 2008 and the Nobel Prize in Medicine in 2024, recognizing his contributions to the field of miRNA research. His work has had far-reaching implications for understanding diseases like cancer and cardiovascular conditions.